Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2585 USD | -4.21% | -17.60% | -85.80% |
04-15 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
04-12 | Portage Biotech Announces Plans to Expand Its Evaluation of Strategic Alternatives | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.80% | 5.34M | |
+27.40% | 48.16B | |
-0.94% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.22% | 25.59B | |
-22.89% | 18.96B | |
+8.07% | 12.92B | |
+29.29% | 12.03B | |
-2.07% | 11.77B |
- Stock Market
- Equities
- PRTG Stock
- News Portage Biotech Inc.
- Portage Biotech to Pause Drug Development in PORT-2 iNKT Program, to Cut Workforce